People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

30.60USD
6 May 2015
Change (% chg)

$-0.03 (-0.10%)
Prev Close
$30.63
Open
$30.83
Day's High
$31.20
Day's Low
$30.03
Volume
107,679
Avg. Vol
265,576
52-wk High
$31.75
52-wk Low
$19.31

Search Stocks

Niederhuber, John 

Dr. John E. Niederhuber, M.D., is an Independent Director of Emergent BioSolutions Inc. since August 2010. He previously served as the director of the National Cancer Institute (NCI), from 2006 to 2010. Dr. Niederhuber joined the Inova Health System in August 2010 as Executive Vice President and CEO of the Inova Translational Medicine Institute. Dr. Niederhuber is also an adjunct investigator at NCI’s Center for Cancer Research and an adjunct professor of surgery and oncology at the Johns Hopkins University School of Medicine. He currently serves on the board of directors of Cellectar Biosciences, Inc. Prior to joining NCI, Dr. Niederhuber was Director of the University of Wisconsin Comprehensive Cancer Center and professor of surgery and oncology (member of the McArdle Laboratory) at the University of Wisconsin School of Medicine from 1997 to 2005. He chaired the Department of Surgery at Stanford University School of Medicine from 1991 to 1997 and held professorships at the Johns Hopkins University School of Medicine from 1987 to 1991 and at the University of Michigan from 1973 to 1987. Dr. Niederhuber is a graduate of Bethany College in Bethany, West Virginia and the Ohio State University School of Medicine. He trained in general surgery at the University of Michigan.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Fuad El-Hibri

3,591,370

Daniel Abdun-Nabi

4,147,390

Robert Kramer

1,917,990

Adam Havey

1,241,980

Barry Labinger

1,298,660

Ronald Richard

--
As Of  30 Dec 2014
Search Stocks